PLoS ONE · 2016 · 38 citations · 29 references
Life SciencesGeneticsImmunologyGenomicsImmunogeneticsStem Cell TransplantationBlood TypingDna SequencingHistocompatibilityHla TypingMajor Histocompatibility ComplexMolecular TypingAmbiguous Hla Typing ResolutionHematopoietic Stem Cell Transplantation ImmunogeneticsHigh-resolution Hla TypingHla AllelesLibrary PreparationMolecular Hla TypingNext-generation Sequencing Hla TypingPaired-end Sequencing
BACKGROUND: Unambiguous HLA typing is important in hematopoietic stem cell transplantation (HSCT), HLA disease association studies, and solid organ transplantation. However, current molecular typing methods only interrogate the antigen recognition site (ARS) of HLA genes, resulting in many cis-trans ambiguities that require additional typing methods to resolve. Here we report high-resolution HLA typing of 10,063 National Marrow Donor Program (NMDP) registry donors using long-range PCR by next generation sequencing (NGS) approach on buccal swab DNA. METHODS: Multiplex long-range PCR primers amplified the full-length of HLA class I genes (A, B, C) from promotor to 3' UTR. Class II genes (DRB1, DQB1) were amplified from exon 2 through part of exon 4. PCR amplicons were pooled and sheared using Covaris fragmentation. Library preparation was performed using the Illumina TruSeq Nano kit on the Beckman FX automated platform. Each sample was tagged with a unique barcode, followed by 2×250 bp paired-end sequencing on the Illumina MiSeq. HLA typing was assigned using Omixon Twin software that combines two independent computational algorithms to ensure high confidence in allele calling. Consensus sequence and typing results were reported in Histoimmunogenetics Markup Language (HML) format. All homozygous alleles were confirmed by Luminex SSO typing and exon novelties were confirmed by Sanger sequencing. RESULTS: Using this automated workflow, over 10,063 NMDP registry donors were successfully typed under high-resolution by NGS. Despite known challenges of nucleic acid degradation and low DNA concentration commonly associated with buccal-based specimens, 97.8% of samples were successfully amplified using long-range PCR. Among these, 98.2% were successfully reported by NGS, with an accuracy rate of 99.84% in an independent blind Quality Control audit performed by the NDMP. In this study, NGS-HLA typing identified 23 null alleles (0.023%), 92 rare alleles (0.091%) and 42 exon novelties (0.042%). CONCLUSION: Long-range, unambiguous HLA genotyping is achievable on clinical buccal swab-extracted DNA. Importantly, full-length gene sequencing and the ability to curate full sequence data will permit future interrogation of the impact of introns, expanded exons, and other gene regulatory sequences on clinical outcomes in transplantation.
29
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Alexandre Loupy, Carmen Lefaucheur, Déwi Vernerey et al. · New England Journal of Medicine · 2013 · 833 citations · Full text
Life Sciences, Immunology, Surgery +17
Michal Chorev, Liran Carmel · Frontiers in Genetics · 2012 · 372 citations · Full text
Differential microRNA regulation of HLA-C expression and its association with HIV control
Smita Kulkarni, Ram Savan, Qi Ying et al. · Nature · 2011 · 330 citations
Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing
Vinzenz Lange, Irina Böhme, Jan A. Hofmann et al. · BMC Genomics · 2014 · 281 citations · Full text